Quantcast

AlleyWatch

The Pulse of New York Tech

Sigilon

Sigilon is a biotech company which specializes in creating immune privileged products for unmet clinical needs. Founded by Omid Veiseh in 2015, Sigilon is backed by investors that include BlackRock, Canada Pension Plan Investment Board, Eli Lilly, Flagship Pioneering, and Longevity Vision Fund and is headquartered in Cambridge.

FOUNDED:
2015
INDUSTRY:
Biotechnology
FOUNDERS:
Omid Veiseh

You are seconds away from signing up for the hottest list in New York Tech!

Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.

Close this popup